EDWARDS LIFESCIENCES LLC

Edwards Lifesciences LLC specializes in the design, manufacturing, and supply of advanced surgical and medical devices, with deep expertise in transcatheter heart valve systems, mitral valve repair implants, and precision prosthetic solutions. The company’s technical capabilities center on electromechanical medical devices, biocompatible materials engineering, and minimally invasive cardiovascular intervention technologies, including TAVR (transcatheter aortic valve replacement) and Pascal mitral implant systems. Their products are engineered for clinical reliability in high-acuity settings, integrating proprietary valve architectures, delivery systems, and tissue processing technologies that meet stringent FDA and ISO 13485 standards. Differentiators include validated performance in complex anatomies, long-term durability data, and integration with real-time imaging guidance platforms. The contractor maintains a dominant presence with the Department of Veterans Affairs, supplying critical cardiac and prosthetic devices to VA medical centers nationwide. Work for the VA centers on procuring life-sustaining implants and surgical supplies for veteran cardiovascular care, with recurring procurement patterns indicating sustained clinical adoption. Limited engagements with the Department of Defense suggest occasional support for military medical readiness programs, though the bulk of activity is concentrated within the VA healthcare system. Primary industry focus lies in surgical appliance and supplies manufacturing (NAICS 339113) and surgical and medical instrument manufacturing (NAICS 339112), positioning the company as a specialized supplier in cardiovascular intervention devices. Vertical specialization includes transcatheter therapies, structural heart implants, and precision surgical tools used in open and percutaneous procedures. The firm operates from Irvine, California, with no public certifications listed, and maintains a focused government market presence through direct supply agreements rather than broad-scale contracting vehicles. Its business model reflects a niche, technology-driven supplier serving high-regulation medical environments with validated, clinically essential products.